Philips delivers first-quarter results in line with 2024 performance improvement plan; Resolves the Respironics personal injury and medical monitoring litigation in the US for USD 1.1 billion
29 avr. 2024 01h00 HE
|
Royal Philips
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion...
CSX Corp. Announces First Quarter 2024 Results
17 avr. 2024 16h01 HE
|
CSX Corporation
JACKSONVILLE, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) today announced first quarter 2024 operating income of $1.35 billion compared to $1.46 billion in the prior year...
Philips convenes the Annual General Meeting of Shareholders 2024
22 mars 2024 04h00 HE
|
Royal Philips
March 22, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and...
Philips publishes its Annual Report 2023
20 févr. 2024 02h30 HE
|
Royal Philips
February 20, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2023. Philips’ Annual Report 2023 will...
Holaluz cumple objetivos de EBITDA normalizado y alcanza los 3M€ en el ejercicio 2023
31 janv. 2024 03h52 HE
|
Holaluz Clidom SA
Barcelona, 31 de enero de 2024 (GLOBE NEWSWIRE) -- Holaluz-Clidom S.A. (BME:HLZ) cumple objetivos de EBITDA normalizado y alcanza los 3M€ en el ejercicio 2023 Holaluz duplica su cuota de mercado...
Holaluz delivers on Normalised EBITDA guidance, reaching 3M€ for FY2023
31 janv. 2024 03h52 HE
|
Holaluz Clidom SA
Barcelona, January 31, 2024 (GLOBE NEWSWIRE) -- Holaluz-Clidom S.A. (BME:HLZ) delivers on Normalised EBITDA guidance, reaching 3M€ for FY2023 Holaluz doubled its solar market share in 2023...
Philips delivers strong full-year results; agrees with FDA on terms of consent decree focused on Philips Respironics in the US
29 janv. 2024 01h00 HE
|
Royal Philips
January 29, 2024 Delivers strong sales growth, improved profitability, and strong cash flow in 2023 through solid execution of first year of 2023-2025 planAgrees with FDA...
Streamline Health® to Report Third Quarter 2023 Financial Performance and Provide Corporate Update
06 déc. 2023 07h30 HE
|
Streamline Health Solutions, Inc.
Atlanta, GA, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to...
Philips delivers strong sales growth, profitability and cash flow; raises full-year outlook
23 oct. 2023 01h00 HE
|
Royal Philips
October 23, 2023 Third-quarter highlights Group sales increased 11% on a comparable basis to EUR 4.5 billionIncome from operations at EUR 224 million, compared to a loss of EUR...
Streamline Health® To Report Second Quarter 2023 Financial Performance and Provide Corporate Update
06 sept. 2023 16h30 HE
|
Streamline Health Solutions, Inc.
Atlanta, GA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to...